Core Insights - The 2025 China International Service Trade Fair (CIFTIS) commenced in September in Beijing, featuring a forum on "Innovations in Tumor Treatment and New Trends in Drug Development" as a key academic activity [1] - The forum aims to create a high-end communication platform for policy interpretation, results release, industry connection, and international cooperation in the field of tumor prevention and treatment [1][3] Group 1: Forum Objectives and Themes - The forum is centered around the theme "Gathering Global Wisdom to Build a New Future in Cancer Prevention" and focuses on promoting disease prevention research and accelerating the transformation of scientific achievements [3] - The event emphasizes the importance of collaboration among government, industry, academia, and research institutions to enhance tumor prevention and treatment [3][4] Group 2: Scientific and Technological Innovations - Keynote speakers highlighted that technological innovation is crucial for the development of precision medicine in oncology, integrating multi-omics technologies, gene editing, liquid biopsy, and artificial intelligence [4] - The proportion of innovative drugs in development, such as cell therapy and bispecific antibodies, has reached 39% in China, marking a significant shift from generic to innovative drug development [4] Group 3: Challenges and Solutions in Cancer Treatment - Experts discussed the challenges in cancer prevention, including low HPV vaccination rates and insufficient screening coverage, particularly in remote areas and among young women [5][6] - A new model for cervical cancer prevention and control was presented, focusing on a multi-dimensional approach that includes immunology, protein, and gene strategies [6] Group 4: Collaborative Research Initiatives - The forum witnessed the launch of a strategic cooperation agreement for a research project aimed at establishing a standardized system for clinical applications of tumor biotherapy [6] - The project involves multiple institutions and aims to create technical standards and clinical pathways to facilitate the safe and compliant transformation of cutting-edge technologies in the industry [6]

Group 1 - The event held in Jinan showcased the city's strengths in the biomedicine industry, particularly in cancer prevention and treatment [3][4] - Jinan is positioning itself as a leading hub for cancer treatment, emphasizing the integration of traditional Chinese and Western medicine [4][5] - The Jinan International Medical Center aims to create a comprehensive cancer treatment ecosystem, leveraging advanced technologies and international standards [5][6] Group 2 - The Jinan International Medical Center has been operational since July 2017, focusing on high-end, specialized, and internationalized healthcare development [5] - The Proton Center, led by Academician Yu Jinming, is a key project that has treated over 1,700 patients and is ranked first in the 2024-2025 China Proton and Heavy Ion Center rankings [5] - The center is collaborating with various institutions to enhance talent and research support for cancer prevention and treatment [6]

Core Insights - The 2025 CACA East China Integrated Oncology Conference was held in Hangzhou, focusing on the theme "Cancer Prevention and Treatment Winning through Integration" [1] - The conference was organized by the Chinese Anti-Cancer Association and Zhejiang Provincial Cancer Hospital, featuring both online and offline formats [1] - The conference aims to promote a comprehensive cancer prevention and treatment strategy through the "Integration" concept, impacting both national and global medical practices [1] Industry Developments - The conference launched the "Core Popular Science Knowledge for Cancer Prevention and Screening in Chinese Residents (2025)", promoting the idea that "prevention is better than treatment" [2] - This publication systematically integrates key content on high-incidence cancers, addressing the fragmentation of prevention knowledge and the lack of unified execution standards [2] - The "Medical-Prevention Integration: Cancer Prevention Empowerment Project (2025-2027)" was officially initiated, aiming to establish a modern cancer prevention and treatment system through five core actions [2] Academic Contributions - Multiple academic sub-sessions were held during the conference, covering all areas of cancer prevention and treatment [2] - These sessions utilized various formats such as thematic reports, case discussions, and technical demonstrations to promote the deep integration of multidisciplinary treatment concepts [2] - The conference aims to inject new momentum into the high-quality development of cancer prevention and treatment [2]

Group 1 - The "2025 CACA North China Integrated Oncology Conference" was held in Beijing from May 23-25, focusing on the theme of "Cancer Prevention and Treatment, Winning through Integration" [1] - The conference was organized by the Chinese Anti-Cancer Association (CACA) and hosted by Peking University Cancer Hospital, gathering experts and scholars in the field of cancer prevention and treatment [1] - The conference aimed to promote the concept of integrated medicine in oncology, with CACA planning to collaborate with regional anti-cancer associations across seven major areas in China to enhance academic exchange [1] Group 2 - The China Association for Science and Technology and CACA launched the "Cancer Innovation Technology Evaluation Index Construction Project" to accelerate the clinical translation of innovative cancer prevention and treatment technologies [2] - The project is supported by the China Association for Science and Technology and will evaluate technologies, with the first phase focusing on lung cancer and breast cancer, gradually expanding to other areas [2]

Group 1 - The core viewpoint emphasizes the significant relationship between obesity and various types of cancer, urging the importance of weight management for cancer prevention [1][2][3] - Obesity is defined as excessive fat accumulation leading to weight beyond the normal range, which increases the risk of not only metabolic diseases but also cancer [2] - The International Agency for Research on Cancer (IARC) identifies a correlation between obesity and the risk of 13 types of cancer, including breast, colorectal, pancreatic, and endometrial cancers [2] Group 2 - The relationship between obesity and cancer involves complex biological mechanisms, including hormonal imbalances and chronic inflammation, which create an environment conducive to cancer cell growth [3][4] - Obesity leads to increased levels of inflammatory markers such as TNF-α and IL-6, which can accelerate tumor cell proliferation and metastasis [3] - Elevated estrogen levels due to obesity are linked to the development of breast and endometrial cancers, with postmenopausal women experiencing a significant increase in estrogen production from fat cells [4] Group 3 - Obesity is associated with various cancers, including colorectal cancer, where chronic inflammation and metabolic abnormalities are key risk factors [6] - The risk of breast cancer is notably higher in obese postmenopausal women, with obesity contributing to poorer prognosis and treatment response [6] - Obesity is a significant risk factor for liver and pancreatic cancers, often linked to insulin resistance and chronic inflammation [6] Group 4 - Effective weight management through diet and exercise is crucial for reducing cancer risk, with recommendations for a balanced diet low in calories, trans fats, and refined sugars [8][9] - Regular physical activity is essential, with guidelines suggesting at least 150 minutes of moderate-intensity aerobic exercise weekly to improve metabolic function and reduce inflammation [10] - Lifestyle adjustments, including smoking cessation and alcohol moderation, are recommended to further mitigate cancer risk [11]

2025年4月15日至21日是第31个全国肿瘤防治宣传周。为扩大癌症防控科普宣传，倡导每个人做自 己健康的第一责任人，人民健康开展"人民好医生·金山茶花计划"系列肿瘤防治科普，邀请金山茶花计 划专家做客人民好医生，围绕肿瘤防治进行系列科普，助力形成加强肿瘤防治的良好社会氛围。 马军，哈尔滨血液病肿瘤研究所所长，中国临床肿瘤学会（CSCO）监事会监事长，亚洲临床肿瘤 学会副主席，中国临床肿瘤学会白血病专家委员会常务委员，国家卫生健康委能力建设与继续教育中心 肿瘤学科专家组组长，《白血病·淋巴瘤杂志》总编辑。 安刚，中国医学科学院血液病医院淋巴肿瘤诊疗中心主任医师、博士生导师，国家优秀青年医师， 中国抗癌协会中国肿瘤青年科学家。 随着人口老龄化和环境的影响，淋巴瘤成为全球范围内发病率增长最快的恶性肿瘤之一，我国每年 新增的淋巴瘤患者数量也在递增。更令人担忧的是，淋巴瘤因其早期症状不典型，容易与其他疾病混 淆，导致误诊和延误治疗。 直播在人民好医生App进行，请扫描二维码下载或在苹果市场、安卓市场搜索"人民好医生"。 二、关注人民健康公众微信号（微信号：rmwjkpd），右下角点击健康互动 "下载人民好医生 App ...